An Ophthalmic Safety Study in Patients With Breast Cancer
Conditions
Ophthalmic Safety in Patients With Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site, La Jolla, California, United States
Research Site, Palo Alto, California, United States
Research Site, Iowa City, Iowa, United States
Research Site, Winston-Salem, North Carolina, United States
Research Site, Clairton, Pennsylvania, United States
Research Site, Pittsburgh, Pennsylvania, United States
Research Site, Sioux Falls, South Dakota, United States
Research Site, Bartlett, Tennessee, United States
Research Site, Houston, Texas, United States
Research Site, CABA, Argentina
Research Site, Córdoba, Argentina
Research Site, Leuven, Belgium
Research Site, Liège, Belgium
Research Site, Alfenas, Brazil
Research Site, Belo Horizonte, Brazil
Research Site, Curitiba, Brazil
Research Site, Lajeado, Brazil
Research Site, Porto Alegre, Brazil
Research Site, Pouso Alegre, Brazil
Research Site, São Paulo, Brazil
Research Site, Sorocaba, Brazil
Research Site, Três Lagoas, Brazil
Research Site, Vitória, Brazil
Research Site, Montreal, Quebec, Canada
Research Site, Montreal, Quebec, Canada
Research Site, Santiago, Chile
Research Site, Santiago, Chile
Research Site, Ashdod, Israel
Research Site, Nahariya, Israel
Research Site, Lodz, Poland
Research Site, Amadora, Portugal
Research Site, Braga, Portugal
Research Site, Seoul, South Korea
Research Site, Badalona, Spain
Research Site, Barcelona, Spain
Research Site, Barcelona, Spain
Research Site, Barcelona, Spain
Research Site, Girona, Spain
Research Site, L'Hospitalet de Llobregat, Spain
Research Site, Leganés, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Majadahonda, Spain
Research Site, Salamanca, Spain
Research Site, Sant Joan Despí, Spain
No study contact email or phone is listed for this trial.